Brian McKelligon
2022
In 2022, Brian McKelligon earned a total compensation of $3M as Chief Executive Officer at Akoya Biosciences, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $630,000 |
|---|---|
| Option Awards | $951,296 |
| Salary | $517,500 |
| Stock Awards | $950,400 |
| Other | $443 |
| Total | $3,049,639 |
McKelligon received $951.3K in option awards, accounting for 31% of the total pay in 2022.
McKelligon also received $630K in non-equity incentive plan, $517.5K in salary, $950.4K in stock awards and $443 in other compensation.
Rankings
In 2022, Brian McKelligon's compensation ranked 1,193rd out of 5,672 executives tracked by ExecPay. In other words, McKelligon earned more than 79.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,193 out of 5,672 | 79th |
Division Manufacturing | 572 out of 3,081 | 81st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 67 out of 471 | 86th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 22 out of 105 | 79th |
Industry Laboratory Analytical Instruments | 13 out of 46 | 72nd |
Source: SEC filing on April 20, 2023.
McKelligon's colleagues
We found two more compensation records of executives who worked with Brian McKelligon at Akoya Biosciences in 2022.